论文部分内容阅读
1999年5月～2002年5月,我们对收治的64例耐多药肺结核病(MDR-TB)患者,以二线药物为主组成化疗方案加胸腺素治疗并与只应用单纯化疗的另58例比较其疗效。现报告如下。 临床资料:本组122例,男76例,女46例,年龄22～62岁。其中原发耐药49例,继发耐药73例,耐异烟肼和利福平98例,耐两种药物以上24例,肺结核病史2～8年。病变范围:1/6～<1/3单侧肺者22例,1/3～<2/3单侧肺者40例,
From May 1999 to May 2002, we treated 64 MDR-TB patients with second-line drug-based chemotherapy plus thymosin and compared with 58 with only chemotherapy alone Compare its efficacy. The report is as follows. Clinical data: The group of 122 cases, 76 males and 46 females, aged 22 to 62 years. Among them, 49 cases were primary drug resistance, 73 cases were secondary drug resistance, 98 cases were resistant to isoniazid and rifampicin, 24 cases were resistant to two kinds of drugs and the history of tuberculosis was 2-8 years. Lesions range: 1/6 ~ <1/3 unilateral lung in 22 cases, 1/3 ~ <2/3 40 cases of unilateral lung,